NO168473C - Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner.Info
- Publication number
- NO168473C NO168473C NO864087A NO864087A NO168473C NO 168473 C NO168473 C NO 168473C NO 864087 A NO864087 A NO 864087A NO 864087 A NO864087 A NO 864087A NO 168473 C NO168473 C NO 168473C
- Authority
- NO
- Norway
- Prior art keywords
- phenylthiazolones
- preparation
- therapeutic active
- analogue procedure
- analogue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78722685A | 1985-10-15 | 1985-10-15 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO864087D0 NO864087D0 (no) | 1986-10-14 |
| NO864087L NO864087L (no) | 1987-04-21 |
| NO168473B NO168473B (no) | 1991-11-18 |
| NO168473C true NO168473C (no) | 1992-02-26 |
Family
ID=25140799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO864087A NO168473C (no) | 1985-10-15 | 1986-10-14 | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0219112A3 (no) |
| JP (1) | JPS6287579A (no) |
| KR (1) | KR900000965B1 (no) |
| CN (1) | CN86107178A (no) |
| AU (1) | AU593289B2 (no) |
| CA (1) | CA1266268A (no) |
| DK (1) | DK489986A (no) |
| HU (1) | HU196774B (no) |
| NO (1) | NO168473C (no) |
| NZ (1) | NZ217897A (no) |
| PH (1) | PH23175A (no) |
| PT (1) | PT83528B (no) |
| ZA (1) | ZA867750B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4866182A (en) * | 1988-02-18 | 1989-09-12 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic alkanoyl and aroyl oxazolones |
| US7091238B1 (en) | 1999-06-21 | 2006-08-15 | University Of Maryland | Thienylhydrazon with digitalis-like properties (positive inotropic effects) |
| AU5628700A (en) * | 1999-06-21 | 2001-01-09 | Edson X. Albuquerque | Thienylhydrazon with digitalis-like properties (positive inotropic effects) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2249091B1 (no) * | 1973-10-25 | 1978-11-17 | Roussel Uclaf | |
| US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
-
1986
- 1986-10-10 CA CA000520328A patent/CA1266268A/en not_active Expired - Lifetime
- 1986-10-13 AU AU63844/86A patent/AU593289B2/en not_active Ceased
- 1986-10-13 ZA ZA867750A patent/ZA867750B/xx unknown
- 1986-10-13 PT PT83528A patent/PT83528B/pt unknown
- 1986-10-13 PH PH34354A patent/PH23175A/en unknown
- 1986-10-13 NZ NZ217897A patent/NZ217897A/xx unknown
- 1986-10-14 NO NO864087A patent/NO168473C/no unknown
- 1986-10-14 CN CN198686107178A patent/CN86107178A/zh active Pending
- 1986-10-14 JP JP61242205A patent/JPS6287579A/ja active Pending
- 1986-10-14 HU HU864276A patent/HU196774B/hu not_active IP Right Cessation
- 1986-10-14 DK DK489986A patent/DK489986A/da not_active Application Discontinuation
- 1986-10-15 EP EP86114263A patent/EP0219112A3/en not_active Withdrawn
- 1986-10-15 KR KR1019860008645A patent/KR900000965B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1266268C (en) | 1990-02-27 |
| JPS6287579A (ja) | 1987-04-22 |
| AU6384486A (en) | 1987-04-16 |
| NO168473B (no) | 1991-11-18 |
| NO864087L (no) | 1987-04-21 |
| HU196774B (en) | 1989-01-30 |
| KR870004008A (ko) | 1987-05-06 |
| EP0219112A2 (en) | 1987-04-22 |
| CN86107178A (zh) | 1987-07-15 |
| PT83528A (en) | 1986-11-01 |
| PH23175A (en) | 1989-05-19 |
| DK489986A (da) | 1987-04-16 |
| PT83528B (pt) | 1989-02-28 |
| AU593289B2 (en) | 1990-02-08 |
| NZ217897A (en) | 1989-04-26 |
| DK489986D0 (da) | 1986-10-14 |
| ZA867750B (en) | 1987-06-24 |
| NO864087D0 (no) | 1986-10-14 |
| HUT45034A (en) | 1988-05-30 |
| CA1266268A (en) | 1990-02-27 |
| EP0219112A3 (en) | 1988-03-23 |
| KR900000965B1 (ko) | 1990-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO162189C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner. | |
| NO884154L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive preparater. | |
| NO874869D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO874153D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
| NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
| NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| NO164295C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. | |
| NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
| NO165071C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO861584L (no) | Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
| NO873680D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser. | |
| NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
| NO864101L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO165542C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. | |
| NO164972C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner. | |
| NO168176C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider | |
| NO874780D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. |